Suephy C Chen, MD, FAAD
SESSIONS
U041 Markers of Risk, Not Pre-melanomas: Case-based Management of Dysplastic Nevi
Mar 8, 2025
•
7:30 AM - 8:30 AM
•
W208A
DISCLOSURES
Sanofi Aventis – Other(Patent royalties or other compensation for Intellectual Property Rights); Syneos Health – Other(Patent royalties or other compensation for Intellectual Property Rights);